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ABSTRACT
Objectives: To determine whether, from a healthcare
perspective, a specific occupational health intervention is
cost effective in reducing sickness absence when
compared with usual care in occupational health in
workers with high risk of sickness absence.
Methods: Economic evaluation alongside a randomised
controlled trial. 418 workers with high risk of sickness
absence from one corporation were randomised to
intervention (n=209) or to usual care (n=209). The
subjects in the intervention group were invited to
occupational health service for a consultation. The
intervention included, if appropriate, a referral to specialist
treatment. Register data of sickness absence were
available for 384 subjects and questionnaire data on
healthcare costs from 272 subjects. Missing direct total
cost data were imputed using a two-part regression
model. Primary outcome measures were sickness
absence days and direct healthcare costs up to 12
months after randomisation. Cost effectiveness (CE) was
expressed as an incremental CE ratio, CE plane and CE
acceptability curve with both available direct total cost
data and missing total cost data imputed.
Results: After one year, the mean of sickness absence
was 30 days in the usual care group (n=192) and
11 days less (95% CI 1 to 20 days) in the intervention
group (n=192). Among the employees with available
cost data, the mean days of sickness absence were 22
and 24, and the mean total cost J974 and J1049 in the
intervention group (n=134) and in the usual care group
(n=138), respectively. The intervention turned out to be
dominant—both cost saving and more effective than
usual occupational health care. The saving was J43 per
sickness absence day avoided with available direct total
cost data, and J17 with missing total cost data imputed.
Conclusions: One year follow-up data show that
occupational health intervention for workers with high risk
of sickness absence is a cost effective use of healthcare
resources.
Sickness absence, defined as non-attendance by an
employee at work due to a health complaint, places
a major economic burden on employers, the
healthcare system and society as a whole. The
optimal occupational health intervention strategy
for employees with high risk of sickness absence
remains uncertain. Evidence from a few rando-
mised trials
12 suggests that specific intervention
programmes targeted at selected individuals at high
risk of sickness absence may provide benefits. It is
not, however, clear whether occupational health
intervention in conjunction with identification of
high-risk employees can generate similar benefits
for employers and employees and also be a cost
effective use of healthcare resources.
A Finnish trial
3 used a health survey in order to
identify subjects with a high risk of sickness
absence. Subsequently, employees in this subgroup
were randomised into additional occupational
health intervention or to usual care at occupational
health. The results showed a clear difference in
favour of the intervention arm in the days of
sickness absence, the primary outcome measure:
on average 11 days for the one-year follow-up
period. The difference in sickness absence was of
such magnitude that is likely to be economically
advantageous, but the cost consequences need to
be considered in order to evaluate the cost
effectiveness of the targeted occupational health
intervention in comparison with usual care in the
high-risk group. We report such an economic
evaluation conducted prospectively alongside the
Finnish occupational health intervention trial.
METHODS
Full details of the randomised controlled trial have
been published previously.
3 In brief, the trial was
conducted to compare the differences between the
occupational health intervention programme and
usual care for employees at high risk of sickness
absence at 12 months. The subjects came from one
corporation in Finland. 49% of them were
employed in the construction industry (civil
engineering, building contracting, technical build-
ing services and building materials industry). The
remaining 51% were employed in the repair, service
and maintenance of buildings, industrial installa-
tions, or communications networks.
At the beginning of the study the employees
(n=1341; 88% males; 62% blue-collar) were
divided into three study groups ‘‘low risk’’
(n=386), ‘‘intermediate risk’’ (n=537) and ‘‘high
risk’’ (n=418) of sickness absence on the basis of a
self-administrated questionnaire with a priori
defined interpretation cut-off limits. Subjects
who reported problems with future working
ability, pain, impairment due to musculoskeletal
problems, insomnia or insufficient sleep, frequent
stress or fatigue, or had a high depression score,
were classified into the high risk group. Of the
employees who met the trial eligibility criteria, 209
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209 to the control group receiving usual care at occupational
health. The interventions were provided between October 2004
and September 2005. At baseline and 12 months, employees
completed the questionnaire, which was used to estimate self-
rated health problems and working ability.
4 At 12 months they
also completed a questionnaire concerning healthcare resource
use during the past 12 months.
Intervention
The employees in the targeted occupational health intervention
group attended the occupational health programme operated by
their own occupational nurses and physicians. They received
personal feedback of their survey results and an invitation to a
consultation at their local occupational health service (OHS).
The main purpose of the consultation was the construction of
an action plan, and if appropriate, referral to a further
consultation by a specialist or psychologist. The visits had a
predefined content including procedures on how to further
diagnose diseases and rules for further actions according to the
process description. The occupational nurse compiled a personal
file for each employee in the intervention group, which included
information about the treatments and health advice received at
the OHS, the referrals to further evaluation or interventions,
the considerations of OHS professionals that no further actions
were needed, and the refusals of some employees to take further
action. 142 (68%) subjects participated in the OHS intervention.
Forty eight occupational health centres were involved in the
intervention programme.
The employees in the control group could consult their
occupational nurse or physician on request, but they did not get
feedback of their health survey results and were not invited for a
consultation.
Outcome measures
Effectiveness was measured primarily by the difference in
sickness absence days between the two groups at follow-up.
Employee-specific sickness absence data, without medical
diagnosis, were obtained from the employer’s records, covering
the period from 1 October 2004 to 30 September 2005.
In a secondary analysis effectiveness was measured by
difference in self-rated health outcomes at follow-up in order
to analyse how the differences in sickness absence between the
treatment arms were related to perceived health and working
ability. At 12 months follow-up, employees were asked in a
postal survey about sleep disturbances, work-related stress and
fatigue, depression, pain, disability due to musculoskeletal
problems, their conception of future working ability, and
changes in their working ability during the past year.
Resource use
In the postal survey at 12 months the employees were also
requested to complete a questionnaire concerning healthcare
resource use during the past 12 months. Table 1 provides an
overview of the resource use, unit costs,
56and mean costs by
items of resource use, and the mean direct total costs (direct
healthcare costs and travelling costs, which can be regarded as
an item of direct non-healthcare costs) based on the subjects,
from whom the resource use data were available. To avoid
double counting, productivity costs were not included, as they
arise from sickness absence days, which was the primary
outcome of the study. All costs are expressed in euros at the
2004 price level.
Statistical methods
Analyses were performed according to the intention-to-treat
principle. Analysis of variance and covariance (ANCOVA) was
used in the comparison of the mean costs and sickness absence
between the groups. Despite the heavily skewed distributions of
these variables, in large samples conventional estimation
methods based on linear regression models are expected to
provide reasonably valid results.
7
Missing total direct cost data were imputed using a two-part
regression model with employee characteristics at baseline and
sickness absence days during the follow-up as explanatory
variables. Employee characteristics used as covariates were: age,
gender, body mass index, working status (white- or blue-collar),
number of health problems (comorbidity), alcohol consump-
tion, physical impairment at work, pain score, insufficient sleep,
and daytime sleepiness. We explored five techniques for
imputation:
8–10 ordinary least squares (OLS), lognormal, gamma
and median regression, and multiple imputation (MICE
package). The first four were applied alone and in combination
with logistic regression (logit) when a two-part method was
used. A priori, a two-part approach was expected to be
most appropriate due to the fact that typically different
processes determine the probability of incurring any cost
(seeking care) and the amounts of costs eventually incurred.
The validity of imputations was explored by dividing the
observations with full data into two groups and using one of
them to produce the prognoses and another for validation.
The predicted accuracy was assessed by using root mean
square error, bias, mean squared prediction error and mean
absolute prediction error. We chose the estimates based on
logit with OLS, because they performed best in the accuracy
tests (data not shown) and were conservative in comparison to
those produced by other methods. Thus, in the first part of the
imputation model, logistic regression was used to predict
whether the employee had any costs or not. In the second
part of the model, OLS regression was used to predict the
direct total cost for those who had incurred any cost. Then
these two predictions were multiplied to impute a cost estimate
for those with missing cost data. The results are reported
both with available total cost data and missing total costs
imputed.
10
To assess uncertainty, one-way (cost variables plus or minus
50% of base value) and probabilistic (bootstrapping with 10 000
replicates) sensitivity analyses were carried out. The latter were
performed for both observed and imputed total cost data.
Results are given as a tornado diagram, mean incremental costs
and effects with their 95% confidence intervals, incremental
cost effectiveness ratio (ICER), cost effectiveness plane, and cost
effectiveness acceptability curve (CEAC).
10
RESULTS
Register data of sickness absence after 12 months of follow-up
were available for 192 (92%) subjects in the intervention
group, and 192 (92%) subjects in the control group: the
employment of 17 subjects had terminated during the follow-
up in both groups. Questionnaire data on healthcare costs
and self-rated health problems were available from 134
subjects (64%) in the intervention group and 138 (67%) subjects
in the control group. Table 2 shows the mean sickness absence
days and the mean (SD) total direct costs in the groups,
subdivided by whether the resource use data were available or
missing.
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Table 1 shows the use of healthcare resources by the groups.
The mean direct total cost using the available cost data was
J974 (range J0–J11 501; quartiles: J184, J399, J939) and
J1049 (range J0–J6908; quartiles: J165, J507, J1340) in the
intervention (n=134) and control (n=138) group, respectively.
With the missing direct total costs imputed the mean was J925
(range J0–J11,501; quartiles: J213, J525, J955) and J1109
(range J0–J6908; quartiles: J250, J625, J1382) in the
intervention (n=192) and control (n=192) group, respectively.
Cost effectiveness analyses
The intervention turned out to be dominant—that is, both cost
saving and more effective than usual occupational health care.
Table 1 The items of resource use, their unit costs, amount of resource use, mean costs (standard deviations) and associated total costs based on
the subjects for whom the resource use data were available
Variable Description Unit cost (J)









UH_days Number of in-patient days at university hospital 636.1 29 24 138 (695) 111 (420)
OHC_doc Doctor visits in occupational health care (OHC) 41.2 419 495 129 (128) 148 (156)
UH_OC Visits at outpatient clinic in a university hospital 202.8 69 47 104 (185) 69 (126)
CH_days Number of in-patient days at central hospital 451.6 26 35 88 (438) 115 (578)
CH_OC Visits at outpatient clinic in a central hospital 183.2 49 30 67 (363) 40 (220)
Oth_phys Physiotherapist visits outside OHC 30.0 272 236 61 (75) 51 (92)
OHC_nur Nurse visits in OHC 22.7 296 235 50 (93) 39 (60)
OHC_phys Physiotherapist visits in OHC 49.7 134 123 50 (194) 44 (121)
Rehab_days Number of in-patient days at rehabilitation 112.7 55 69 46 (274) 56 (323)
RH_OC Visits at outpatient clinic in a regional hospital 179.8 29 53 39 (214) 69 (145)
PH_days Number of in-patient days at private hospital 510.2 9 1 34 (355) 4 (43)
PH_GP General practitioner visits in public healthcare 65.6 67 76 33 (80) 36 (66)
Oth_Cons Visits at other private consultant 79.6 44 53 26 (64) 31 (101)
Orthop Visits at private orthopaedic consultant 121.0 26 32 23 (82) 28 (117)
OHC_other Visits at other healthcare professionals in OHC 33.9 60 46 15 (70) 11 (44)
RH_days Number of in-patient days at regional hospital 400.2 5 24 15 (91) 70 (407)
PH_nur Nurse visits in public healthcare 30.5 36 46 8 (25) 10 (55)
Priv_GP General practitioner visits in private healthcare 57.9 18 36 8 (40) 15 (51)
CHCW_days Number of in-patient days at community health centre 148.0 6 0 7 (77) 0 (0)
MHC Visits at mental health clinic 108.1 8 10 6 (47) 8 (28)
Oth_OC Visits at other hospital outpatient clinics 191.2 4 3 6 (211) 4 (212)
Tel_adv Telephone health advice 17.4 38 83 5 (20) 10 (26)
UH_n Number of visits at university hospital 30.9 19 20 4 (20) 4 (17)
CH_n Number of visits at central hospital 30.9 18 17 4 (22) 4 (14)
Psych Visits at private psychiatrist or psychologist 88.1 6 75 4 (39) 48 (453)
RH_n Number of visits at regional hospital 30.9 9 34 2 (14) 8 (46)
Rehab_n Number of visits at in-house rehabilitation centre 13.2 9 15 1 (4) 1 (12)
OthH_n Number of visits at other hospital 6.0 7 2 0 (3) 0 (1)
PH_n Number of visits at private hospital 13.2 1 3 0 (1) 0 (2)
OthH_days Number of in-patient days at other hospitals 510.2 0 4 0 (0) 15 (137)
CHCW_n Number of visits at community health centre ward 6.0 0 1 0 (0) 0 (1)
Mean direct total cost 974 1049
Total costs 130469 144741
The source for the unit costs was Hujanen
5 for all other items except Kansanela ¨kelaitos
6 for ‘‘Rehab_days’’. The unit costs are expressed in euros at the 2004 price level.
Table 2 The mean number of sickness absence days (register data) at baseline and at follow-up as well as the mean and standard deviation (SD) for
direct total costs
Availability of resource
use data Study group Group size
Sick leave days per group
Direct total cost Baseline Follow-up
% zero Mean SD % zero Mean SD % zero Mean SD
Data available Control 138 36 16.9 37 25 23.7 45 4 1048.9 1368
Intervention 134 29 18.2 34 32 22.0 50 4 973.6 1628
Data missing Control 54 31 17.4 29 19 45.8 67 4 1261.3 1183 *
Intervention 58 21 15.4 29 29 13.1 25 3 813.0 746 *
All Control 192 34 17.1 35 23 29.9 53 4 1108.6 1319 {
Intervention 192 27 17.4 32 31 19.3 44 4 925.1 1420 {
*Direct cost data are based on missing data imputation.
{Direct cost data are partly based on missing data imputation.
The results are presented by randomised groups among those subjects for whom the resource use questionnaire data were available, resource use data were missing, and for all
subjects.
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by using the available direct cost data and data with missing
total costs imputed, respectively.
With available total cost data from the 272 subjects (and
sickness absence data from the same subjects) one-way
sensitivity analyses revealed that the result was not sensitive
to any cost variables: the incremental cost-effectiveness ratio
varied from 2J59 to 2J28 per sickness absence day avoided—
that is, in all cases the intervention was dominant (fig 1). The
probabilistic sensitivity analysis showed that the mean incre-
mental cost was 2J80 (95% CI 2429 to +290) and the mean
incremental effect 1.8 days (95% CI 29.7 to +12.4) of avoided
work absence. The cost effectiveness plane suggested that for
about half of the simulated cases the intervention was cost
saving and more effective (fig 2A). At any level of societal
willingness to pay for a sickness absence day avoided the
probability of the intervention being acceptable is around 60–
70% (fig 3).
With available total cost data from the 272 subjects and
missing total cost data imputed for 112 subjects (and sickness
absence register data from all the 384 subjects) the probabilistic
sensitivity analysis resulted in a mean incremental cost of
2J180 (95% CI 2452 to +98) and a mean incremental effect of
10.5 days (95% CI 0.6 to +20.4) of avoided work absence.
According to the cost effectiveness plane in over 90% of the
simulated cases the intervention was cost saving and more
effective (fig 2B). If the societal willingness to pay for a sickness
absence day avoided was, for example, J60 then the probability
that the intervention is acceptable would be 97% (fig 3).
Health outcomes
Table 3 shows the self-rated health outcomes by the groups. No
difference was found in self-rated working ability, or perceived
change in working ability between the groups. Neither was any
difference found in the prevalence of distinct health problems
(depression, fatigue, stress, pain, physical impairment, insom-
nia) between the groups. However, depression, fatigue and
stress tended to be more prevalent in the control group than in
the intervention group at 12-month follow-up. If the effective-
ness of intervention is measured in terms of health outcomes,
the intervention seems to be weakly dominant—that is, it
produces the same effectiveness at a lower cost.
DISCUSSION
Main findings
The intervention, a personal feedback of the health survey
results and an invitation to a consultation at the local OHS, was
cost-saving and more effective in reducing sickness absence than
usual occupational health care (dominant in terms of health
economics
10). The cost-effectiveness was not sensitive to any
cost variables and the result did not change whether we used
available cost data or data where missing total costs were
imputed. The health survey outcome measures showed that the
differences between the two groups were minimal concerning
the subjects’ self-rated health problems. In other words, the
intervention produced the same (self-rated) health outcomes at
a lower cost than usual care.
Strengths and weaknesses of the study
Our primary outcome was based on register data on sickness
absence, which has several advantages: good coverage, accuracy
and consistency.
11 We were able to collect sickness absence data
for all employees, whose employment still continued at the 12-
month follow-up time point (n=192 in both groups). The
resource use data were collected by a questionnaire in a postal
survey, and we received 134 responses in the intervention group
and 138 responses in the usual care group. The overall response
rate of about 70% in a postal survey is reasonably high.
Comparison of the number of sickness absence days between
the intervention and usual care (control) groups among
employees with complete data and among employees with
available cost data indicated however that the total cost data of
employees were not missing completely at random (table 2). It
appeared that the non-respondents in the usual care (control)
group had significantly more sickness absence than the
respondents, while such difference between the respondents
and non-respondents in the intervention group was not found.
This difference may be a side-effect of the intervention:
participation in the intervention may have reduced the usual
non-responding tendency among the most high-risk subjects.
Figure 1 Tornado diagram showing the
influence of changing values of any
variable (SD 50%) on incremental cost
effectiveness ratio (ICER) when other
variables remain in their base values. In
the graph variables are ranked on the
basis of their influence (the most
influential variable is on the top). The
meanings of the abbreviations are shown
in the table 1.
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necessary to produce less biased cost-effectiveness results. A
two-part approach to imputation was chosen due to the fact
that typically different processes determine the probability of
seeking care and the amounts of costs eventually incurred.
Several regression techniques were explored in part two of the
two-part approach. We chose the results based on OLS
regression, because it performed best in the accuracy tests and
produced conservative estimates in comparison with other
methods. Therefore the imputed total costs are more likely
underestimates rather than overestimates of the real total costs.
One-way sensitivity analyses revealed that the result was not
sensitive to any cost variables. The cost effectiveness accept-
ability curves indicate that when the uncertainty both on the
cost and effectiveness side is accounted for in the probabilistic
sensitivity analysis, the intervention is acceptable in about 70%
Figure 2 Cost effectiveness planes.
Base case results indicated by a diamond.
(A) With cost data based on the survey
responses. In 49.9% of simulated cases
intervention was both cost saving and
more effective (Quadrant IV), in 17.7%
cost saving and less effective (Quadrant
III), in 12.5% more costly and more
effective (Quadrant II), and in 19.9% of
cases more costly and less effective
(Quadrant I). (B) With missing cost data
imputed. In 89.5% of simulated cases
intervention was both cost saving and
more effective (Quadrant IV), in 0.9% cost
saving and less effective (Quadrant III), in
8.7% more costly and more effective
(Quadrant II), and in 0.9% of cases more
costly and less effective (Quadrant I).
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day avoided in the base case, in which only data from the
subjects for whom the direct total cost were available were
used. With missing total costs imputed the acceptability rises to
well over 90% at all levels of willingness to pay. As the number
of sickness days was observed to increase from the baseline less
in the intervention group than in the control group, it is
probable that the use of health services and thus costs would
also increase less, making the cost difference between the groups
larger. Therefore, the almost 70% acceptability in the base case
probably represents a ‘‘worst case scenario’’ and is already an
indication of the superiority of the intervention. Using the
whole set of the register data on sickness absences, and
imputing the missing total cost data, probably leads to the
least biased estimate of the acceptability (around 90%), even
though imputation does bring some uncertainty around this
estimate.
The health outcomes were based on available data, as
imputation was not feasible. Therefore these results should be
interpreted with caution as the non-responding to the postal
survey was not completely at random. Missing data may have
biased the health-related results against the intervention group.
Some differences compared with previous studies
Systematic reviews of (randomised) trials on occupational
health care provide little evidence of any one approach being
more effective than another. Trials on the efficacy of occupa-
tional health interventions vary in methodological quality,
study populations, interventions, reference treatments and
outcome measures, leading to a conclusion that no single
approach can be favoured over another yet. Some evidence from
randomised trials, however, has shown that specific interven-
tions for specific conditions,
12–15 or for selected high-risk
groups,
12may be effective in the occupational health setting.
Some of the randomised controlled trials evaluating the
effectiveness of specific treatments in the occupational health-
care setting have also included an economic evaluation.
15–17
However, none of the previous studies focusing on high-risk
subgroups has carried out such an evaluation. This seems to be
the first study to assess cost effectiveness for a specific
intervention programme for employees at high risk of sickness
absence. However, it is yet to be assessed whether the savings
due to the reduction of sickness absence and health resource use
in the high risk group exceed the investment in the whole
screening process. The cost for the screening for the original
3115 subjects invited was about J46,000.
Meaning of the study
The intervention arm of this study applied a pragmatic
approach: the employees’ own occupational nurses and physi-
cians carried out the occupational health intervention. The key
difference between the intervention and usual care treatment
arms was the invitation to OHS for an additional consultation,
and subsequent disease-specific interventions when applicable.
With the health survey and subsequent invitation to OHS we
succeeded in capturing many workers with underlying health
problems that had not been properly attended to. Of the
subjects who visited OHS, more than half had not received
treatment for the respective health problem at OHS before.
3
The direct costs related to occupational health care (table 1)
did not differ between the groups during the intervention
period, which was an unexpected result. We can suggest some
possible explanations. First, the OHS personnel had access to a
pre-classified and valid biopsychosocial profile while taking care
of the subjects in the intervention group. This diminished the
need to spend time taking the history, and subsequently the
OHS personnel could focus on the overall treatment plan for the
underlying health issues. Second, the care path through OHS
consultation may have functioned more effectively. 45% of the
employees who attended the consultation were referred to a
further consultation by a specialist, or to specific interventions.
Despite so many referrals to specialist care, the intervention was
eventually cost-saving in comparison with usual care. It appears
that the subjects in the usual care group used healthcare
resources in public or private health care even more. Third,
perhaps the intervention group subjects were intervened earlier
than the subjects in the usual care group.
The usual care in occupational health in this specific company
included, besides medical treatment, regular health check-up
visits with OHS nurses, targeted for all employees. However the
intervention was superior in controlling sickness absence and
reduced healthcare resource use. This indicates that health
check-ups by OHS nurses, while targeted at all employees, may
not represent an optimal use of scarce OHS resources. Instead,
our results support the application of interventions that are
targeted at selected employees who are at high risk of sickness
absence and work disability.
Figure 3 Cost effectiveness acceptability curves with total cost data
based on questionnaire responses (base case analysis), and total cost
data with imputed missing values (imputed total cost data).
Table 3 Changes in working ability and the presence of health





95% CI of the
difference
Change in working ability (%)
Much better 1 4
Slightly better 13 11
No change 47 49
Slightly worse 31 31
Much worse 8 6
Presence of health problems (%)
Depression 14 8 23t o1 4
Fatigue 8 4 22t o1 1
Stress 7 2 21t o1 1
Pain 19 20 211 to 9
Physical impairment 58 51 25t o1 9
Insomnia 11 11 28t o8
Working ability 49 52 215 to 9
Depression OR fatigue OR stress 19 11 21t o1 7
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controlled trial, showed that the invitation of individuals at
high risk for sickness absence to a consultation at occupational
health care reduces both sickness absence days and healthcare
costs while providing the same health outcomes as usual care.
Our results may have implications on OHS policies. Perhaps
there should be a shift in the OHS resource use from non-
targeted health check-ups towards identifying and intervening
the individuals at a high risk of sickness absence and work
disability. Future studies in different settings and professional
groups are called for.
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Policy implication
Health check-ups by OHS nurses while targeted for all employees
may not be an optimal use of OHS resources. The results of the
present study give support for interventions that are targeted to
selected employees at a high risk of sickness absence and work
disability.
Main messages
c An occupational health intervention, which included an
invitation to occupational health service (OHS) for a
consultation and, if appropriate, a referral to specialist
treatment, was cost saving and more effective in reducing
sickness absence than usual occupational health care among
employees at high risk of sickness absence.
c The cost effectiveness was not sensitive to any reasonable
changes in the values of cost variables.
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